239 related articles for article (PubMed ID: 24754244)
1. Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.
Ghosh M
Am J Reprod Immunol; 2014 Jun; 71(6):575-88. PubMed ID: 24754244
[TBL] [Abstract][Full Text] [Related]
2. Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens.
Wira CR; Fahey JV; Rodriguez-Garcia M; Shen Z; Patel MV
Am J Reprod Immunol; 2014 Aug; 72(2):236-58. PubMed ID: 24734774
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications.
Yarbrough VL; Winkle S; Herbst-Kralovetz MM
Hum Reprod Update; 2015; 21(3):353-77. PubMed ID: 25547201
[TBL] [Abstract][Full Text] [Related]
4. Influence of common mucosal co-factors on HIV infection in the female genital tract.
Ferreira VH; Kafka JK; Kaushic C
Am J Reprod Immunol; 2014 Jun; 71(6):543-54. PubMed ID: 24617528
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.
Wira CR; Patel MV; Ghosh M; Mukura L; Fahey JV
Am J Reprod Immunol; 2011 Mar; 65(3):196-211. PubMed ID: 21294805
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.
Keller MJ; Madan RP; Torres NM; Fazzari MJ; Cho S; Kalyoussef S; Shust G; Mesquita PM; Louissaint N; Chen J; Cohen HW; Diament EC; Lee AC; Soto-Torres L; Hendrix CW; Herold BC
PLoS One; 2011 Jan; 6(1):e16475. PubMed ID: 21283552
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection.
Choi MW; Isidoro CA; Gillgrass A
Curr Opin Virol; 2024 Jun; 66():101398. PubMed ID: 38484474
[TBL] [Abstract][Full Text] [Related]
8. New approaches to making the microenvironment of the female reproductive tract hostile to HIV.
Fahey JV; Bodwell JE; Hickey DK; Ghosh M; Muia MN; Wira CR
Am J Reprod Immunol; 2011 Mar; 65(3):334-43. PubMed ID: 21223421
[TBL] [Abstract][Full Text] [Related]
9. Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research.
Venkatesh KK; Cu-Uvin S
Am J Reprod Immunol; 2014 Jun; 71(6):495-504. PubMed ID: 24832617
[TBL] [Abstract][Full Text] [Related]
10. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
Firoz Mian M; Ashkar AA
Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
[TBL] [Abstract][Full Text] [Related]
11. The role of serpin and cystatin antiproteases in mucosal innate immunity and their defense against HIV.
Aboud L; Ball TB; Tjernlund A; Burgener A
Am J Reprod Immunol; 2014 Jan; 71(1):12-23. PubMed ID: 24325760
[TBL] [Abstract][Full Text] [Related]
12. Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.
Lahey T; Ghosh M; Fahey JV; Shen Z; Mukura LR; Song Y; Cu-Uvin S; Mayer KH; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
PLoS One; 2012; 7(6):e38100. PubMed ID: 22675510
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium.
Nazli A; Kafka JK; Ferreira VH; Anipindi V; Mueller K; Osborne BJ; Dizzell S; Chauvin S; Mian MF; Ouellet M; Tremblay MJ; Mossman KL; Ashkar AA; Kovacs C; Bowdish DM; Snider DP; Kaul R; Kaushic C
J Immunol; 2013 Oct; 191(8):4246-58. PubMed ID: 24043886
[TBL] [Abstract][Full Text] [Related]
14. HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.
Cole AM; Cole AL
Viruses; 2017 May; 9(5):. PubMed ID: 28505117
[TBL] [Abstract][Full Text] [Related]
15. Female genital tract immunity: distinct immunological challenges for vaccine development.
Naz RK
J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
Cole AM; Cole AL
Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
[TBL] [Abstract][Full Text] [Related]
17. The impact of aging on innate and adaptive immunity in the human female genital tract.
Rodriguez-Garcia M; Patel MV; Shen Z; Wira CR
Aging Cell; 2021 May; 20(5):e13361. PubMed ID: 33951269
[TBL] [Abstract][Full Text] [Related]
18. The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract.
Wira CR; Rodriguez-Garcia M; Shen Z; Patel M; Fahey JV
Am J Reprod Immunol; 2014 Aug; 72(2):171-81. PubMed ID: 24661500
[TBL] [Abstract][Full Text] [Related]
19. Engineering immunity in the mucosal niche against sexually transmitted infections.
Ramanathan R; Woodrow K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):107-22. PubMed ID: 26153141
[TBL] [Abstract][Full Text] [Related]
20. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract.
Vitali D; Wessels JM; Kaushic C
AIDS Res Ther; 2017 Sep; 14(1):39. PubMed ID: 28893284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
